Non-catalytic substrate-selective p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof
US11911392B2 · kind B2 · utility
0Cited by
6References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 9, 2022 |
| Grant date | Feb 27, 2024 |
| Priority date | — |
| Expiry date | May 18, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds that inhibit p38α MAPK protein, and methods of using the same, are provided for treating or preventing diseases such as cancer or inflammatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.